| 臺大學術典藏 |
2021-05-27T08:20:58Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
JYH-MING LIOU; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:57Z |
Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesions
|
Lee Y.-C.; Chiu H.-M.; Chiang T.-H.; Yen A.M.-F.; Chiu S.Y.-H.; Chen S.L.-S.; Fann J.C.-Y.; Yeh Y.-P.; Liao C.-S.; Hu T.-H.; Tu C.-H.; Tseng P.-H.; Chen C.-C.; Chen M.-J.; JYH-MING LIOU; Liao W.-C.; Lai Y.-P.; Wang C.-P.; Ko J.-Y.; Wang H.-P.; Chiang H.; Lin J.-T.; Chen H.-H.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:57Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
JYH-MING LIOU; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2021-05-27T08:20:54Z |
Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan
|
Cheng A.; Sheng W.-H.; JYH-MING LIOU; Wang H.-P.; Wu M.-S.; Lin J.-T.; Chang S.-C. |
| 臺大學術典藏 |
2021-05-27T08:20:53Z |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
Fang Y.-J.; JYH-MING LIOU; Chen C.-C.; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; Chen C.-C.; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:53Z |
Consensus of gastroesophageal reflux disease in Taiwan with endoscopy-based approach covered by National Health Insurance
|
Sheu B.-S.; Chiu C.-T.; Lee Y.-C.; Chang C.-Y.; Wu D.-C.; JYH-MING LIOU; Wu M.-S.; Chang W.-L.; Wu C.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2021-05-27T08:20:53Z |
The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study
|
JYH-MING LIOU; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; Wang H.-P.; Sheu B.-S.; Lin J.-T.; Bair M.-J.; Wu M.-S.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Lee Y.-C.; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:52Z |
Associations of circulating gut hormone and adipocytokine levels with the spectrum of gastroesophageal reflux disease
|
Tseng P.-H.; Yang W.-S.; JYH-MING LIOU; Lee Y.-C.; Wang H.-P.; Lin J.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:51Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
JYH-MING LIOU; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:51Z |
Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of Helicobacter pylori infection
|
Chen M.-J.; JYH-MING LIOU; Chen C.-C.; Lee Y.-C.; Chang C.-Y.; Wu J.-Y.; Bair M.-J.; Lin J.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:51Z |
Prevention of gastric cancer by helicobacter pylori eradication: Current evidence and future prospects
|
JYH-MING LIOU; Lin J.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:50Z |
Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection
|
Chen P.-Y.; Wu M.-S.; Chen C.-Y.; Bair M.-J.; Chou C.-K.; Lin J.-T.; JYH-MING LIOU; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:49Z |
Treatment of Helicobacter pylori infection: Where are we now?
|
JYH-MING LIOU; Wu M.-S.; Lin J.-T. |
| 臺大學術典藏 |
2021-05-27T08:20:49Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
JYH-MING LIOU; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:49Z |
Bismuth and Non-bismuth Quadruple Therapy for Helicobacter pylori Eradication: Time to Make the Switch in Clinical Practice?
|
JYH-MING LIOU; Lin J.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:49Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
JYH-MING LIOU; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:48Z |
Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
|
Tsai K.-F.; JYH-MING LIOU; Chen M.-J.; Chen C.-C.; Kuo S.-H.; Lai I.-R.; Yeh K.-H.; Lin M.-T.; Wang H.-P.; Cheng A.-L.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:47Z |
Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials
|
Chen M.-J.; Wu M.-S.; Chen C.-C.; Chen C.-C.; Fang Y.-J.; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; Hsu W.-F.; Luo J.-C.; Lin J.-T.; JYH-MING LIOU; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:47Z |
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis
|
Kuo Y.-T.; JYH-MING LIOU; El-Omar E.M.; Wu J.-Y.; Leow A.H.R.; Goh K.L.; Das R.; Lu H.; Lin J.-T.; Tu Y.-K.; Yamaoka Y.; Wu M.-S.; for the, Asian Pacific Alliance on Helicobacter; Microbiota |
| 臺大學術典藏 |
2021-05-27T08:20:47Z |
Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale
|
Sheu B.-S.; Wu M.-S.; Chiu C.-T.; Lo J.-C.; Wu D.-C.; JYH-MING LIOU; Wu C.-Y.; Cheng H.-C.; Lee Y.-C.; Hsu P.-I.; Chang C.-C.; Chang W.-L.; Lin J.-T. |
| 臺大學術典藏 |
2021-05-27T08:20:46Z |
First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: A systematic review and network meta-analysis
|
Yeo Y.H.; Shiu S.-I.; Ho H.J.; Zou B.; Lin J.-T.; Wu M.-S.; JYH-MING LIOU; Wu C.-Y. |
| 臺大學術典藏 |
2021-05-27T08:20:45Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
JYH-MING LIOU; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; JYH-MING LIOU; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:45Z |
Survey of the adherence to the consensus of gastroesophageal reflux disease before and after the implementation course
|
JYH-MING LIOU; Sheu B.-S.; Lee Y.-C.; Cheng H.-C.; Chang W.-L.; Wu D.-C.; Hsu P.-I.; Wu C.-Y.; Wu M.-S.; Chiu C.-T.; Lin J.-T. |
| 臺大學術典藏 |
2021-05-27T08:20:45Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
JYH-MING LIOU; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:44Z |
Systematic review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection
|
Chen M.-J.; Chen C.-C.; Chen Y.-N.; Chen C.-C.; Fang Y.-J.; Lin J.-T.; Wu M.-S.; JYH-MING LIOU; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:44Z |
The implementation of the consensus on the management of Helicobacter pylori and barriers to consensus
|
Cheng H.-C.; JYH-MING LIOU; Luo J.-C.; Chiu C.-T.; Wu M.-S.; Lee Y.-C.; Wu C.-Y.; Wu D.-C.; Hsu P.-I.; Chang C.-C.; Chang W.-L.; Lin J.-T.; Sheu B.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:43Z |
Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication
|
Yeo Y.H.; Hsu C.-C.; Lee C.-C.; Ho H.J.; Lin J.-T.; Wu M.-S.; JYH-MING LIOU; Wu C.-Y.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:42Z |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
|
JYH-MING LIOU; Chen C.-C.; Chang C.-M.; Fang Y.-J.; Bair M.-J.; Chen P.-Y.; Chang C.-Y.; Hsu Y.-C.; Chen M.-J.; Chen C.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chen C.-Y.; Hsu W.-F.; Chen Y.-N.; Wu J.-Y.; Lin J.-T.; Lu T.-P.; Chuang E.Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T02:50:23Z |
Endoscopic measurement of gastric mucosal blood flow by laser doppler flowmetry in liver cirrhotics and non-cirrhotics
|
Lin B.R.; JYH-CHIN YANG; Wang J.-T.; Yue C.-H.; Lin J.-T.; Wang T.-H. |
| 臺大學術典藏 |
2021-05-27T02:50:23Z |
Detection of Helicobacter pylori in gastric biopsy tissue by polymerase chain reaction
|
Wang J.T.; Lin J.T.; Sheu J.C.; JYH-CHIN YANG; Chen D.S.; Wang T.H. |
| 臺大學術典藏 |
2021-05-27T02:50:22Z |
Mucinous cystic neoplasm of the pancreas: Cysto-ductectatic variant type in a Chinese patient
|
Chan T.-M.; Lin J.-T.; Wang J.-T.; Lee P.-H.; How S.-W.; JYH-CHIN YANG; Wang T.-H. |
| 臺大學術典藏 |
2021-05-27T02:50:21Z |
Prospective, randomized study of H2-blocker and triple therapy for duodenal ulcer treatment and the eradication of Helicobacter pylori
|
Lin J.-T.; Wang J.-T.; Wu M.-S.; Lee W.-Y.; JYH-CHIN YANG; Wang T.-H. |
| 臺大學術典藏 |
2021-05-27T02:50:19Z |
Isolation of a Helicobacter pylori protein, FldA associated with mucosa- associated lymphoid tissue lymphoma of the stomach
|
Chang C.-S.; Chen L.-T.; JYH-CHIN YANG; Lin J.-T.; Chang K.-C.; Wang J.-T. |
| 臺大學術典藏 |
2021-05-27T02:50:19Z |
Molecular mechanisms of clarithromycin resistance in Helicobacter pylori
|
Hsieh P.-F.; JYH-CHIN YANG; Lin J.-T.; Wang J.-T. |
| 臺大學術典藏 |
2021-05-27T02:50:19Z |
Antibody to a Helicobacter pylori species specific antigen in patients with adenocarcinoma of the stomach
|
Wang J.-T.; Chang C.-S.; Lee C.-Z.; JYH-CHIN YANG; Lin J.-T.; Wang T.-H. |
| 臺大學術典藏 |
2021-05-27T02:50:19Z |
Optimized conditions for growth and fermentation of Helicobacter pylori.
|
Wang J.T.; Chang C.S.; JYH-CHIN YANG; Lin J.T.; Wang T.H. |
| 臺大學術典藏 |
2021-05-27T02:50:18Z |
Accurate diagnosis of Helicobacter pylori infection by stool antigen test and 6 other currently available tests in children
|
Ni Y.-H.; Lin J.-T.; Huang S.-F.; JYH-CHIN YANG; Chang M.-H. |
| 臺大學術典藏 |
2021-05-27T02:50:18Z |
The role of gastric acid and Helicobacter pylori in the natural course of duodenal ulcer.
|
JYH-CHIN YANG; Lin B.R.; Wang J.T.; Chen W.H.; Lin J.T.; Wang T.H. |
| 臺大學術典藏 |
2021-05-27T02:50:16Z |
CagA tyrosine phosphorylation in gastric epithelial cells caused by Helicobacter pylori in patients with gastric adenocarcinoma
|
Lai Y.-P.; JYH-CHIN YANG; Lin T.-Z.; Wang J.-T.; Lin J.-T. |
| 臺大學術典藏 |
2021-05-27T02:50:16Z |
Limited value of typical gastroesophageal reflux disease symptoms to screen for erosive esophagitis in Taiwanese
|
Lin B.-R.; Wong J.-M.; JYH-CHIN YANG; Wang J.-T.; Lin J.-T.; Wang T.-H. |
| 臺大學術典藏 |
2021-05-27T02:50:14Z |
Erratum: Helicobacter pylori infection and CagA protein translocation in human primary gastric epithelial cell culture (Helicobacter (2006) 11, (451-459))
|
Lai Y.-P.; JYH-CHIN YANG; Lin T.-Z.; Lin J.-T.; Wang J.-T. |
| 臺大學術典藏 |
2021-05-27T02:50:14Z |
Helicobacter pylori infection and CagA protein translocation in human primary gastric epithelial cell culture
|
Lai Y.-P.; JYH-CHIN YANG; Lin T.-Z.; Lin J.-T.; Wang J.-T. |
| 臺大學術典藏 |
2021-05-26T09:08:28Z |
Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancers
|
Hsu C.-H.; Yeh K.-H.; Chen L.-T.; Liu J.M.; Jan C.-M.; Lin J.-T.; YAO-CHANG CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-05-26T09:08:25Z |
Relatively low expression of multidrug resistance-1 (MDR-1) and its possible clinical implication in gastric cancers
|
Yeh K.-H.; Chen C.-L.; Shun C.-T.; Lin J.-T.; Lee W.-J.; Lee P.-H.; YAO-CHANG CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-05-26T09:08:24Z |
High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy
|
Yeh K.-H.; Shun C.-T.; Chen C.-L.; Lin J.-T.; Lee W.-J.; Lee P.-H.; YAO-CHANG CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-05-26T09:08:24Z |
Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19) - Possible clinical significance in advanced gastric cancer
|
Yeh K.-H.; YAO-CHANG CHEN; Yeh S.-H.; Chen C.-P.; Lin J.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-05-26T09:08:22Z |
Overexpression of p53 is not associated with drug resistance of gastric cancers to 5-fluorouracil-based systemic chemotherapy
|
Yeh K.-H.; Shun C.-T.; Chen C.-L.; Lin J.-T.; Lee W.-J.; Lee P.-H.; YAO-CHANG CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-05-14T05:40:08Z |
Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
|
Chen C.-C.; Lee J.-Y.; Fang Y.-J.; Hsu S.-J.; MING-LUN HAN; Tseng P.-H.; Liou J.-M.; Hu F.-C.; Lin T.-L.; Wu M.-S.; Wang H.-P.; Lin J.-T. |
| 臺大學術典藏 |
2021-05-07T06:02:25Z |
Incidence and mortality of pancreatic cancer on a rapid rise in Taiwan, 1999–2012
|
Tseng C.-M.;Huang S.-P.;Liao W.-C.;Chun-Ju Chiang;Yang Y.-W.;Chang C.-Y.;Hsu Y.-C.;Chen H.-C.;Chiang H.-S.;Lin J.-T.; Tseng C.-M.; Huang S.-P.; Liao W.-C.; CHUN-JU CHIANG; Yang Y.-W.; Chang C.-Y.; Hsu Y.-C.; Chen H.-C.; Chiang H.-S.; Lin J.-T. |
| 臺大學術典藏 |
2021-05-07T05:13:42Z |
Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-κB activation
|
Chang Y.J.; Wu M.S.; Lin J.T.; Sheu B.S.; Muta T.; Inoue H.; CHING-CHOW CHEN |
